Bacterial respiratory infections, particularly those caused by pathogens such as Streptococcus pneumoniae, Klebsiella pneumoniae, Legionella pneumophila, Haemophilus influenzae and Bordetella pertussis, pose a serious health threat, especially to vulnerable groups such as the elderly, young children and people with weakened immune systems. These infections can lead to serious illness, including pneumonia, bronchitis and whooping cough, making rapid and accurate detection critical for effective patient management and public health response.

The iCassette Diagnostic Kit for Streptococcus pneumoniae, Klebsiella pneumoniae, Legionella pneumophila, Haemophilus influenzae and Bordetella pertussis is an advanced diagnostic tool designed for the in vitro qualitative detection of these important respiratory pathogens. Using real-time multiplex fluorescence PCR technology, this kit provides rapid, reliable results from respiratory specimens, enabling healthcare providers to rapidly diagnose and treat bacterial infections.

The iCassette uses a magnetic bead transfer structure and process technology, as well as a material distributed mixing device structure. It is compatible with the Galaxy: Nano, Lite and Pro. The test can be performed on demand with no minimum batch size requirement, which is advantageous for clinics and hospitals that require rapid results. The fully automated sample magnetic beads extraction to qPCR process provides results in one and a half hours with minimal hands-on time, increasing laboratory efficiency and reducing patient waiting times.

The iCassette SP/KP/LP/HI/BP Diagnostic Kit is suitable with nasopharyngeal swab and sputum. It is stored at 2-8°C and includes internal process control to ensure the accuracy and reliability of each test performed.

With the ability to detect multiple pathogens in a single test, the iCassette Diagnostic Kit supports efficient and effective diagnosis, enabling timely intervention and improved patient outcomes. This kit is an essential resource for healthcare facilities focused on accurate and rapid diagnosis of bacterial infections, ultimately improving the quality of patient care and helping to control bacterial respiratory diseases.